Wolfgang Pricken

Retired Managing Director of Medtronic GmbH; Excited Grandpa; Humanist; Friend of Elixir Medial & Fan of a sophisticated PCI

[Wolfgang Pricken @WPricken]

@Rainmaker1973 Bounty Bob

[Wolfgang Pricken @WPricken]

If restenosis were a person, it would now be rightfully worried about its existence 🎸💫 @AGIKinterv @YoungDgk @DGK_org

[Elixir Medical Corp @ElixirMed]

Today at #EuroPCR 2025, researchers presented the 3-year outcomes from the BIOADAPTOR-RCT, offering confirmation of the durability of the treatment—with sustained significantly lower TLF rates with the DynamX® Coronary Bioadaptor System compared to third-generation DES.

Dr. Shigeru Saito shared data showing lower TLF rates (2.7% vs. 7.2%) at 3 years follow-up.

The results also highlighted the continued separation of MACE event curves, supporting the role of bioadaptor technology in restoring vessel physiology and improving patient outcomes over time.

These findings mark an important milestone in coronary intervention.

#DynamX #Bioadaptor #ClinicalData #Medtech #Cardiology #RCT

[Wolfgang Pricken @WPricken]

Q.E.D. - DynamX delivers what Bioresorbable promised 🎸💫 @AGIKinterv @YoungDgk @DGK_org

[Elixir Medical Corp @ElixirMed]

Today at #EuroPCR 2025, researchers presented the 3-year outcomes from the BIOADAPTOR-RCT, offering confirmation of the durability of the treatment—with sustained significantly lower TLF rates with the DynamX® Coronary Bioadaptor System compared to third-generation DES.

Dr. Shigeru Saito shared data showing lower TLF rates (2.7% vs. 7.2%) at 3 years follow-up.

The results also highlighted the continued separation of MACE event curves, supporting the role of bioadaptor technology in restoring vessel physiology and improving patient outcomes over time.

These findings mark an important milestone in coronary intervention.

#DynamX #Bioadaptor #ClinicalData #Medtech #Cardiology #RCT

[Wolfgang Pricken @WPricken]

If you can arrange it, you shouldn‘t miss it 🎸#PerfectPCI @AGIKinterv @YoungDgk @DGK_org

[Elixir Medical Corp @ElixirMed]

We’re excited to join the global interventional cardiovascular community in Paris for #EuroPCR2025, taking place May 20–23.

Elixir Medical technologies will be featured in several sessions, including presentations of new clinical data results, and will host two symposia covering the significant new clinical insights including:

3-year outcomes from the #BIOADAPTOR RCT

• Real-world evidence on #DynamX performance
• 24-month results from the DESyne BDS Plus RCT
• Highlights of recent cases using LithiX Hertz Contact #lithotripsy (#IVL)

We’re proud to be a leader in ongoing PCI innovation. Check out the full agenda and schedule for sessions and symposia.

#Medtech #Cardiology #Innovation #Bioadaptor #Lithotripsy

[Wolfgang Pricken @WPricken]

DynamX is rocking the world 🎸. Hear from the experts in #Mannheim why DynamX will also transform Cardiology in Germany - sooner or later. Save the Date:
Wednesday, April 23, 2025, at 5:30 p.m. in Hall 19
Join us, in person or online. As a special treat, we'll be showcasing the latest developments from LithiX, a simple yet ingenious approach to intravascular lithotripsy. #PerfectPCI @AGIKinterv @mirvatalasnag @Kardiophil @Hannah_Billig_ @HolgerNef @NikosWerner @doc_cardio @KardiologieHH @thiele_holger @DGK_org

[Elixir Medical Corp @ElixirMed]

Amazing launch of DynamX™ Bioadaptor in Egypt with @AlhyattGroup Heart & Vascular Center led by Dr. @hazemwarda! 3-day workshop including live lecture by Dr. @Antocol17 & 10 successful cases – 1st DynamX cases in Egypt & all of Africa!

#DynamX #Alhyatt #CardioTwitter

[Wolfgang Pricken @WPricken]

DynamX is rocking the world 🎸. Hear from the experts in #Mannheim why DynamX will also transform Cardiology in Germany - sooner or later. Save the Date:
Wednesday, April 23, 2025, at 5:30 p.m. in Hall 19
Join us, in person or online. As a special treat, we'll be showcasing the latest developments from LithiX, a simple yet ingenious approach to intravascular lithotripsy. #PerfectPCI @AGIKinterv @mirvatalasnag @Kardiophil @Hannah_Billig_ @HolgerNef @NikosWerner @doc_cardio @KardiologieHH @thiele_holger @DGK_org

[Elixir Medical Corp @ElixirMed]

Attending #CRT2025?

Join us today at 11:30am in the Spotlight Theater for the Spotlight Session on bioadaptive angioplasty.

Faculty: Ron Waksman, David Erlinge, Shigeru Saito, Dean Kereiakes, MD, FACC, MSCAI, Mirvat Alasnag, Tamil Selvan Muthusamy, Pier Pasquale Leone

#DynamX

[Wolfgang Pricken @WPricken]

Always worth a read 👍

[Cian McCarthy @CianPMcCarthy]

The eagerly awaited 2025 ACC/AHA ACS guidelines were released yesterday! Congrats to @SVRaoMD @DrM_ODonoghue and all the co-authors

1/ Here are some of my takeways

[Wolfgang Pricken @WPricken]

Legend ✨

[Angioplasty.Org @angioplastyorg]

Thanks @Hragy for posting this from the recent @IMCLIVEcongress. Here's the full clip of Andreas Gruentzig discussing "Complications" from my interview with him in 1985, just weeks before his untimely death. #AngioHistory

[Joana Cotar @JoanaCotar]

Ich fahre an den ganzen Wahlplakaten der Ampel vorbei und denke mir: ernsthaft?

Mir absolut unerklärlich, wie Menschen das noch glauben können.

[Wolfgang Pricken @WPricken]

Great Initiative.

[European Society of Cardiology @escardio]

🚨 New #ESCCardioTalk episode alert! 🚨

This week, Shinwan Kany & @shaan_khurshid explore another piece in the atrial fibrillation puzzle! 🧩💡
From clinical insights to genetic risk and AI-powered ECG analysis, this episode covers it all! Don’t miss out on the latest in heart health innovation. 💥❤️

🎙️ Listen now https://t.co/kh5bTI16yy

#EHJ #CVD

[Wolfgang Pricken @WPricken]

Please join 🍿. You won‘t regret it. #BeyondDES #BioadaptiveAngioplasty @cardiotwitt @AGIKinterv

[AGIK @AGIKinterv]

🔥 Save the Date! 🔥

#AGIK Women lädt am 07.–08.11 nach Düsseldorf ein: Herzklappenvitium – was dann?

Spannendes Thema mit führenden Expertinnen: Prof. Dr. @tk_rudolph, PD Dr. @GaedeLuise und PD Dr. Maike Knorr.

Sei dabei: https://t.co/Ti1T2eYI1K

[Holger Nef @HolgerNef]

Bench data for DCB

1️⃣Trackability of DCB
2️⃣particle release
3️⃣drug release

measured by @AlperOener. 👌👍

#DGKHerztage
#innovation
@Steph_Achenbach @mmamas1973 @KardiologieHH @dscharpfMD @mirvatalasnag @MarcVorpahl @thiele_holger @DrCathaHamm

[Wolfgang Pricken @WPricken]

@AlaAahram Wise Words 👌

[Wolfgang Pricken @WPricken]

Another technical Inspiration from Elixir Medical for the #PerfectPCI. Please get familiar with it. @AGIKinterv

[Radcliffe Cardiology @radcliffeCARDIO]

Dive into this two-part series on Hertz Contact Intravascular Lithotripsy and the PINNACLE I study with Dr @valeriaparadies, Dr @mirvatalasnag and Dr Stefan Verheye 🔗Stream now 👉 https://t.co/LbNnXsMfga

📊 Part 1: Uncover the Hertz Contact technology and PINNACLE I findings
🥼 Part 2: Explore clinical endpoints, results and practice impacts

#PINNACLEIStudy #Cardiology #ClinicalTrials #CardioTwitter

[Wolfgang Pricken @WPricken]

#BioadaptiveAngioplasty #PerfectPCI Please pay attention to the Plateau 🙏💪

[Elixir Medical Corp @ElixirMed]

🚨INFINITY-SWEDEHEART: #DynamX® Bioadaptor meets primary endpoint and significantly reduces adverse events vs. DES after six months!

Full data: https://t.co/JHaax2X9sn

CE marked. Not for sale in the U.S.

#cardiotwitter #ESC2024

PMN 2001 REV A

[Wolfgang Pricken @WPricken]

If you are in London for the ESC 2024, please do not miss this one #PerfectPCI #BeyondDES @AGIKinterv @DGK_org

[Elixir Medical Corp @ElixirMed]

At #ESC2024, we’ll unveil late-breaking, 12-month primary outcomes from the 2,400-patient INFINITY-SWEDEHEART RCT evaluating #DynamX compared to contemporary DES. Read more: https://t.co/2LZvfpUazw

@DavidErlinge
@stjam367

CE marked. Not for sale in the U.S.

PMN 1894 REV A

[Akhmetzhan Galimzhanov @AkhmetzhanG]

Happy to publish our #SysRev supervised by Prof @mmamas1973 ! Excited to be a part of this fantastic team! Thank you all🙏!
Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis https://t.co/VQLCGeVB1w

#EJPC #Cardiology #cardioOncology

[Wolfgang Pricken @WPricken]

Rockin‘ all over the world 🎸 #PerfectPCI #BeyondDES @AGIKinterv @DGK_org

[Elixir Medical Corp @ElixirMed]

At #EuroPCR 2024, global experts discussed complex procedures performed with #DynamX® Coronary Bioadaptor System & how restoring vessel viability leads to clinical benefits.

https://t.co/hfMWcDM4mL

CE marked. Not for sale in the U.S.

PMN 1938 REV A